PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
17.55%
Net income growth under 50% of MCHP's 114.79%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-0.40%
Both reduce yoy D&A, with MCHP at -3.09%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
11.76%
Some yoy growth while MCHP is negative at -460.12%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
9.52%
SBC growth well above MCHP's 11.30%. Michael Burry would flag major dilution risk vs. competitor’s approach.
106.69%
Well above MCHP's 110.08% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
157.85%
AR growth well above MCHP's 257.12%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-6550.00%
Negative yoy inventory while MCHP is 101.46%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
23.73%
A yoy AP increase while MCHP is negative at -216.90%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
87.54%
Some yoy usage while MCHP is negative at -176.29%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
125.00%
Some yoy increase while MCHP is negative at -2.81%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
102.12%
Operating cash flow growth above 1.5x MCHP's 4.05%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
19.25%
CapEx growth well above MCHP's 25.94%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
61.46%
Purchases growth of 61.46% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
10.50%
Below 50% of MCHP's 100.00%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-2380.00%
Both yoy lines negative, with MCHP at -7.98%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
73.97%
We have mild expansions while MCHP is negative at -7.98%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
33.24%
We repay more while MCHP is negative at -22.51%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-40.41%
Negative yoy issuance while MCHP is 176.71%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
46.25%
Buyback growth of 46.25% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.